Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.
Cui M, Shoucair S, Liao Q, Qiu X, Kinny-Köster B, Habib JR, Ghabi EM, Wang J, Shin EJ, Leng SX, Ali SZ, Thompson ED, Zimmerman JW, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Zheng L, He J, Zhao Y, Wolfgang CL, Yu J.
Cui M, et al. Among authors: ali sz.
Int J Surg. 2023 Feb 1;109(2):99-106. doi: 10.1097/JS9.0000000000000200.
Int J Surg. 2023.
PMID: 36799816
Free PMC article.